The Rationale Driving the Evolution of Deep Brain Stimulation to Constant-Current Devices von Bronstein, Jeff M., Tagliati, Michele, McIntyre, Cameron, Chen, Robert, Cheung, Tyler, Hargreaves, Eric L., Israel, Zvi, Moffitt, Michael, Montgomery, Erwin B., Stypulkowski, Paul, Shils, Jay, Denison, Timothy, Vitek, Jerrold, Volkman, Jens, Wertheimer, Jeffrey, Okun, Michael S.

Volltext

Technology of deep brain stimulation: current status and future directions von Krauss, Joachim K., Lipsman, Nir, Aziz, Tipu, Boutet, Alexandre, Brown, Peter, Chang, Jin Woo, Davidson, Benjamin, Grill, Warren M., Hariz, Marwan I., Horn, Andreas, Schulder, Michael, Mammis, Antonios, Tass, Peter A., Volkmann, Jens, Lozano, Andres M.

Volltext

Cytokines and growth factors cross-link heparan sulfate von Migliorini, Elisa, Thakar, Dhruv, Kühnle, Jens, Sadir, Rabia, Dyer, Douglas P., Li, Yong, Sun, Changye, Volkman, Brian F., Handel, Tracy M., Coche-Guerente, Liliane, Fernig, David G., Lortat-Jacob, Hugues, Richter, Ralf P.

Volltext

Comparative modeling and docking of chemokine-receptor interactions with Rosetta von Wedemeyer, Michael J., Mueller, Benjamin K., Bender, Brian J., Meiler, Jens, Volkman, Brian F.

Volltext

Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion von MCNEEL, Douglas G, EICKHOFF, Jens, JIANLIANG ZHANG, HAMMERSHAIMB, Luz, ZWIEBEL, James A, WILDING, George, LEE, Fred T, KING, David M, ALBERTI, Dona, THOMAS, James P, FRIEDL, Andreas, KOLESAR, Jill, MARNOCHA, Rebecca, VOLKMAN, Jennifer

Volltext

Phase I Trial of a Monoclonal Antibody Specific for a sub(v){szligbeta} sub(3) Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumo... von McNeel, Douglas G, Eickhoff, Jens, Lee, Fred T, King, David M, Alberti, Dona, Thomas, James P, Friedl, Andreas, Kolesar, Jill, Marnocha, Rebecca, Volkman, Jennifer, Zhang, Jianliang, Hammershaimb, Luz, Zwiebel, James A, Wilding, George

Volltext

Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion von McNeel, Douglas G, Eickhoff, Jens, Lee, Fred T, King, David M, Alberti, Dona, Thomas, James P, Friedl, Andreas, Kolesar, Jill, Marnocha, Rebecca, Volkman, Jennifer, Zhang, Jianliang, Hammershaimb, Luz, Zwiebel, James A, Wilding, George

Volltext